The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of acquired immune deficiency syndromes (1999) 2019-05, Vol.81 (1), p.e17-e21
Hauptverfasser:	Rossetti, Barbara, Gagliardini, Roberta, Sterrantino, Gaetana, Colangeli, Vincenzo, Latini, Alessandra, Colafigli, Manuela, Vignale, Francesca, Rusconi, Stefano, Di Biagio, Antonio, Orofino, Giancarlo, Mezzaroma, Ivano, Vullo, Vincenzo, Francisci, Daniela, Mastroianni, Claudio, Trezzi, Michele, Canovari, Benedetta, Lamonica, Silvia, Ciccullo, Arturo, Borghetti, Alberto, DʼArminio Monforte, Antonella, Di Giambenedetto, Simona, De Luca, Andrea
Format:	Artikel
Sprache:	eng
Schlagworte:	AIDS/HIV Anti-HIV Agents - administration & dosage Anti-HIV Agents - therapeutic use Antiretroviral drugs Antiretroviral Therapy, Highly Active - methods Antiviral drugs Darunavir - administration & dosage Darunavir - therapeutic use Disease Progression Drug Substitution Female Fibrosis HIV Infections - drug therapy HIV-1 - drug effects Humans Letters to the Editor Liver Cirrhosis - chemically induced Liver Cirrhosis - prevention & control Male Maraviroc - administration & dosage Maraviroc - therapeutic use Middle Aged Ritonavir Ritonavir - administration & dosage Ritonavir - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!